EN
我们的产品
PRODUCTS
Position:
Homepage
/
products

products

Time of issue:2021-10-20 15:55:13

Name

CAS No.

Indication

Key Intermediates(CAS No)

(VC Code)

Contact info

Saxagliptin

945667-22-1

Diabetes

709031-45-8

66-8

[Business group 1]

Contact Us:

Manager Yue

Tel:

+86-177015180264

QQ:834729175

E-mail:yue_meng@

vcarepharmatech

.com

361442-00-4

65-7

361440-67-7

66-7

Edoxaban (TsOH salt hydrate)

1229194-11-9

Anticoagulant

480449-70-5

304-1F

1210348-34-7

516-0

720720-96-7

518-1

1243308-37-3

517-1

Lurasidone

(Intermediates ONLY)

367514-87-2

Schizophrenia

14805-29-9

194-2

65376-05-8

188-5A

186204-35-3

188-6A

Obeticholic Acid

 

459789-99-2

NAFLD

1516887-33-4

310-100

915038-26-5

310-8

Apixaban

503612-47-3

Anticoagulant

27143-07-3

266-2

545445-44-1

268-7

503614-91-3

262-4

Upadacitinib(ABT-494)

1310726-60-3

JAK

1428243-26-8

568-1

1201186-54-0

569-1

1201187-44-1

569-100

1869118-24-0

569-200

Eltrombopag olamine

496775-62-3

Thrombocytopenia of ITP patients

116557-46-1

47-4

376592-93-7

512-1

277299-70-4

513-1

 

Parecoxib sodium

198470-85-8

Postoperative pain

37928-17-9

246-17

Cangrelor

 

163706-36-3

Acute coronary syndromes

163706-58-9

504-1

163706-61-4

301-2

Baricitinib

1187595-84-1

Rheumatoid Arthritis

1029716-44-6

541-1

1187595-85-2

540-1

941685-27-4

542-1

Ruxolitinib phosphate

1092939-17-7

MF

941685-26-3

542-2

591769-05-0

607-1

Tetrabenazine

58-46-8

Huntington's disease

91342-74-4

67-12

20232-39-7

67-9

Valbenazine
(NBI-98854)

1025504-45-3

Huntington's disease

1026016-83-0

67-24

85081-18-1

67-25

Deutetrabenazine

1392826-25-3

Huntington’s disease

4593-96-8

555-50A

1783808-87-6

555-1

89929-27-1

333-50

Ixazomib

1201902-80-8

Multiple myeloma

179324-87-9

201-7

667403-46-5

534-1

Baloxavir marboxil

1985606-14-1

Anti influenza

1985607-70-2

561-1

1985607-83-7

559-1

Lesinurad

878672-00-5

GOUT

878671-99-9

309-3

1533519-84-4

309-4

1533519-92-4

309-5

Products for sales in the country/region without IP conflict or for R&D purpose only

 

Name

CAS No.

Indication

Key Intermediates(CAS No)

VC Code

Contact info

Ticagrelor

274693-27-5

Acute coronary syndromes

145783-15-9

152-34

[Business group 2]

Contact Us:

Manager Wang

Tel:

+86-18061209485 QQ:

643625451

E-mail:

sales07@

vcarepharmatech

.com

1156491-10-9

152-20

376608-71-8

152-19

220352-39-6

152-321

376608-65-0

152-47

376608-74-1

152-70

274693-26-4

152-72

LCZ696

936623-90-4

Heart Failure

1369773-39-6

306-4

1012341-50-2

525-1

1012341-48-8

525-10

Empagliflozin

864070-44-0

Diabetes

915095-94-2

551-1

915095-89-5

551-100

32384-65-9

567-2

915095-99-7

337-5

Dapagliflozin

461432-26-8

Diabetes

461432-23-5

563-1

1103738-29-9

563-100

714269-57-5

574-1

Roxadustat

808118-40-3

CKD

1455091-10-7

564-1

1809286-36-9

NA

2244489-55-0

NA

2170880-59-6

564-101

Tofacitinib citrate

540737-29-9

Rheumatoid Arthritis

3680-69-1

264-5

1062580-52-2

209-5A

923036-30-0

321-4

477600-74-1

321-6

Sotagliflozin

1018899-04-1

Diabetes

1103738-19-7

566-1

Relugolix

737789-87-6

Endometriosis/or fibroids

1589503-95-6

572-1

7252-84-8

573-1

308831-94-9

572-7

Rimegepant

1289023-67-1

Anti migraine

39713-40-1

583-6

1190363-46-2

583-1

1209456-28-9 

584-1

1373116-06-3

584-100

Ubrogepant

1374248-77-7

Anti migraine

1455358-14-1

585-1

1375470-88-4

586-1

1456803-37-4

586-100

Mirogabalin

1138245-13-2

PNP

1235479-61-4

587-1

Vonoprazan(TAK-438)

1260141-27-2

Ulcer

881674-56-2

308-6

16133-25-8

308-21

Fezolinetant

1629229-37-3

Hot Flush

1383146-20-0

595-1

1375066-73-1

596-1

Vericiguat

1350653-20-1

Chronic Heart Failure

1350653-26-7

597-1

Abrocitinib

1622902-68-4

AD (Atopic dermatitis)

23761-23-1

601-100

1353501-22-0

601-1

这是描述信息

Contact Us

Add:No. 136, Huakang Road, Jiangbei New Area, Nanjing, P. R. China

这是描述信息

Scan to see

Copyright © Jiangsu Vcare PharmaTech Co. Ltd.,

中兴能源